APA (7th ed.) Citation

Burmester, G. R., Buttgereit, F., Bernasconi, C., Álvaro-Gracia, J. M., Castro, N., Dougados, M., . . . collaborators, S. (2020). Continuing versus tapering glucocorticoids after achievement of low disease activity or remission in rheumatoid arthritis (SEMIRA): A double-blind, multicentre, randomised controlled trial. Lancet, 396(10246), 267. https://doi.org/10.1016/S0140-6736(20)30636-X

Chicago Style (17th ed.) Citation

Burmester, Gerd R., et al. "Continuing Versus Tapering Glucocorticoids After Achievement of Low Disease Activity or Remission in Rheumatoid Arthritis (SEMIRA): A Double-blind, Multicentre, Randomised Controlled Trial." Lancet 396, no. 10246 (2020): 267. https://doi.org/10.1016/S0140-6736(20)30636-X.

MLA (9th ed.) Citation

Burmester, Gerd R., et al. "Continuing Versus Tapering Glucocorticoids After Achievement of Low Disease Activity or Remission in Rheumatoid Arthritis (SEMIRA): A Double-blind, Multicentre, Randomised Controlled Trial." Lancet, vol. 396, no. 10246, 2020, p. 267, https://doi.org/10.1016/S0140-6736(20)30636-X.